Immorna

嘉晨西海(杭州)生物技术有限公司

Morrisville, United States · Founded 2019 · $63.8M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$63.8M
Last Round
$3.8M GrantAug 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Immorna Biotherapeutics is a clinical-stage biotechnology company founded in 2019, focused on developing next-generation RNA-based therapeutics and vaccines utilizing conventional, self-replicating, and circular mRNA platforms. The company's pipeline spans tumor immunotherapy, infectious disease vaccines, rare diseases, and medical cosmetology, with lead program JCXH-213 targeting CD19. Headquartered in Morrisville, North Carolina, with operations also in Hangzhou, China, Immorna serves patients and healthcare systems globally through its proprietary CMC and delivery systems.

Summary

Immorna is a Biotech company based in Morrisville, United States, founded in 2019. It has raised $63.8M in total across 4 rounds, most recently a $3.8M Grant round in Aug 2024. Investors include Bill & Melinda Gates Foundation, RTW Investments and Qatar Investment Authority.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantAug 2024
$3.8M

Sign up to see all 4 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Immorna on Indexed.vc
<a href="https://indexed.vc/companies/immorna"><img src="https://indexed.vc/api/badge/company/immorna" alt="Immorna on Indexed.vc" width="260" height="76" /></a>